Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Repaglinide“
Suchtreffer
Begriffe & Kennungen
Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenCoAprovel · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenDeferasirox Accord · 4.5 · 11 deferasirox with repaglinide should be avoided. If the combination appears necessary, careful clinical and
Eintrag öffnenDeferasirox Accord · 4.5 · Interaction with repaglinide and other agents metabolised by CYP2C8
Eintrag öffnenEnyglid · 4.3 · - Hypersensitivity to repaglinide or to any of the excipients listed in section 6.1. - Diabetes mellitus type
Eintrag öffnenEnyglid · 4.5 · A number of medicinal products are known to influence repaglinide metabolism, possible interactions should the
Eintrag öffnenEnyglid · 4.5 · Based on in vitro data, repaglinide appears to be a substrate for active hepatic uptake (organic anion transpo
Eintrag öffnenEnyglid · 4.5 · Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates
Eintrag öffnenEnyglid · 4.5 · Co-administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and repaglinide (a single dose
Eintrag öffnenEnyglid · 4.5 · Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single
Eintrag öffnenEnyglid · 4.5 · In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of 0.
Eintrag öffnenEnyglid · 4.5 · In vitro data indicate that repaglinide is metabolised predominantly by CYP2C8, but also by CYP3A4. Clinical d
Eintrag öffnenEnyglid · 4.5 · Repaglinide had no clinically relevant effect on the pharmacokinetic properties of digoxin, theophylline or wa
Eintrag öffnenEnyglid · 4.5 · The following substances may enhance and/or prolong the hypoglycaemic effect of repaglinide: Gemfibrozil, clar
Eintrag öffnenEnyglid · 4.5 · The following substances may reduce the hypoglycaemic effect of repaglinide: Oral contraceptives, rifampicin,
Eintrag öffnenEnyglid · 4.5 · When repaglinide is used together with other medicinal products that are mainly secreted by the bile, like rep
Eintrag öffnen